- Previous Close
51.31 - Open
39.88 - Bid 41.05 x 1300
- Ask 40.15 x 900
- Day's Range
36.02 - 43.22 - 52 Week Range
11.20 - 72.98 - Volume
77,381,305 - Avg. Volume
16,812,168 - Market Cap (intraday)
8.856B - Beta (5Y Monthly) 1.35
- PE Ratio (TTM)
75.21 - EPS (TTM)
0.53 - Earnings Date May 5, 2025 - May 9, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
42.45
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.
www.forhims.com1,637
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: HIMS
View MoreRelated Videos: HIMS
Performance Overview: HIMS
Trailing total returns as of 2/25/2025, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HIMS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HIMS
View MoreValuation Measures
Market Cap
8.86B
Enterprise Value
8.57B
Trailing P/E
75.21
Forward P/E
80.65
PEG Ratio (5yr expected)
4.52
Price/Sales (ttm)
6.39
Price/Book (mrq)
18.58
Enterprise Value/Revenue
5.80
Enterprise Value/EBITDA
108.45
Financial Highlights
Profitability and Income Statement
Profit Margin
8.54%
Return on Assets (ttm)
7.18%
Return on Equity (ttm)
30.71%
Revenue (ttm)
1.48B
Net Income Avi to Common (ttm)
126.04M
Diluted EPS (ttm)
0.53
Balance Sheet and Cash Flow
Total Cash (mrq)
300.25M
Total Debt/Equity (mrq)
2.38%
Levered Free Cash Flow (ttm)
178.69M
Research Analysis: HIMS
View MoreCompany Insights: HIMS
HIMS does not have Company Insights
Research Reports: HIMS
View MoreRaising target price to $61.00
HIMS & HERS HEALTH INC has an Investment Rating of HOLD; a target price of $61.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetRaising target price to $46.00
HIMS & HERS HEALTH INC has an Investment Rating of HOLD; a target price of $46.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetRaising target price to $44.00
HIMS & HERS HEALTH INC has an Investment Rating of HOLD; a target price of $44.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetRaising target price to $33.00
HIMS & HERS HEALTH INC has an Investment Rating of HOLD; a target price of $33.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice Target